Oscar Health, Inc. (NYSE:OSCR) Receives $21.56 Consensus Price Target from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus recommendation of “Hold” by the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $21.56.

A number of equities analysts have commented on OSCR shares. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company.

Insider Activity

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total value of $426,250.00. Following the transaction, the director now directly owns 89,512 shares in the company, valued at approximately $1,526,179.60. This trade represents a 21.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was bought at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the acquisition, the director now directly owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Point72 Hong Kong Ltd acquired a new stake in shares of Oscar Health in the 2nd quarter worth $78,000. Quest Partners LLC acquired a new position in shares of Oscar Health in the 2nd quarter valued at about $93,000. KBC Group NV lifted its holdings in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after buying an additional 1,328 shares during the period. ORG Wealth Partners LLC purchased a new stake in Oscar Health during the 4th quarter worth approximately $100,000. Finally, Amalgamated Bank increased its stake in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $15.92 on Friday. The business’s fifty day moving average price is $15.03 and its 200-day moving average price is $16.83. Oscar Health has a one year low of $10.45 and a one year high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. Oscar Health’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter last year, the company posted ($0.29) earnings per share. On average, research analysts anticipate that Oscar Health will post -0.01 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.